Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | MMP2 | P08253 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | GMNN | O75496 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11042843 | 0.89 | SHBG (0.42) | SHBGEPHX1CA12CA1CA2 | |
| SCHEMBL9756560 | 0.82 | SHBG (0.41) | SHBGEPHX1CA12CA1CA2 | |
| SCHEMBL1911124 | 0.82 | SHBG (0.41) | SHBGEPHX1CA12CA1CA2 | |
| SCHEMBL13002271 | 0.79 | SHBG (0.37) | SHBGEPHX1CA12CA1CA2 | |
| SCHEMBL2354256 | 0.79 | SHBG (0.42) | SHBGEPHX1TP53KDM4EGMNN | |
| SCHEMBL10136483 | 0.77 | SHBG (0.41) | SHBGEPHX1TP53KDM4EGMNN | |
| SCHEMBL1911127 | 0.74 | SHBG (0.43) | SHBGEPHX1TP53KDM4EGMNN | |
| SCHEMBL9512108 | 0.74 | SHBG (0.43) | SHBGEPHX1TP53KDM4EGMNN | |
| SCHEMBL13244488 | 0.74 | SHBG (0.43) | SHBGEPHX1TP53KDM4EGMNN | |
| SCHEMBL12197569 | 0.72 | SHBG (0.37) | SHBGEPHX1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9244352-B2 | Coating compositions for use with an overcoated photoresist | ROHM AND HAAS ELECTRONIC MATERIALS, LLC (US) | 2016-01-26 | — | — | US | disclosed |
| US-8501383-B2 | Coating compositions for use with an overcoated photoresist | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2013-08-06 | — | — | US | disclosed |
| US-20110033800-A1 | COATING COMPOSITIONS FOR USE WITH AN OVERCOATED PHOTORESIST | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2011-02-10 | — | — | US | disclosed |
| US-20110033801-A1 | COATING COMPOSITIONS FOR USE WITH AN OVERCOATED PHOTORESIST | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2011-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110033800-A1 | COATING COMPOSITIONS FOR USE WITH AN OVERCOATED PHOTORESIST | METTL14, PCMT1, MGMT | SHBG 3074/4885EPHX1 1403/4885CA12 467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.